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Clostridium difficile is a bacterial pathogen that causes major
health challenges worldwide. It has a well-characterized surface
(S)-layer, a para-crystalline proteinaceous layer surrounding the
cell wall. In many bacterial and archaeal species, the S-layer is
glycosylated, but no such modifications have been demon-
strated in C. difficile. Here, we show that a C. difficile strain of
S-layer cassette type 11, Ox247, has a complex glycan attached
via an O-linkage to Thr-38 of the S-layer low-molecular-weight
subunit. UsingMS andNMR, we fully characterized this glycan.
We present evidence that it is composed of three domains: (i) a
core peptide–linked tetrasaccharide with the sequence -4--
Rha-3--Rha-3--Rha-3--Gal-peptide; (ii) a repeating pen-
tasaccharide with the sequence -4--Rha-4--Glc-3--Rha-4-
(-Rib-3-)-Rha-; and (iii) a nonreducing end–terminal 2,3
cyclophosphoryl-rhamnose attached to a ribose-branched sub-
terminal rhamnose residue. The Ox247 genome contains a
24-kb locus containing genes for synthesis and protein attach-
ment of this glycan.Mutations in genes within this locus altered
or completely abrogated formation of this glycan, and their phe-
notypes suggested that this S-layer modification may affect
sporulation, cell length, and biofilm formation of C. difficile.
In summary, our findings indicate that the S-layer protein of
SLCT-11 strains displays a complex glycan and suggest that this
glycan is required for C. difficile sporulation and control of cell
shape, a discovery with implications for the development of
antimicrobials targeting the S-layer.
The Gram-positive anaerobe Clostridium difficile remains a
highly problematic bacterial pathogen, both in hospital envi-
ronments and in the community (1, 2). It can cause severe gas-
trointestinal disease, mediated largely through the production
of two toxins, TcdA and TcdB, that glycosylate host gastroin-
testinal GTPases resulting in damage to gut tissues and unreg-
ulated inflammatory reactions (3). Transmission of C. difficile
infection (CDI)8 is through robust spores produced in the intes-
tine as part of the normal life cycle of the bacterium (4). Vege-
tativeC. difficile cells are resistant tomost common antibiotics,
with only a few selected antimicrobials used to treat CDI (1).
Animal and clinical studies have demonstrated that broad spec-
trum antibiotics act as predisposing agents for CDI, through
selective killing of members of the normal gut microbiota,
allowing germination of C. difficile spores and proliferation of
the vegetative cells (5–7).
The cell surface ofC. difficile has been studied in some detail.
Covering the entire surface of vegetative cells is an S-layer, a
proteinaceous para-crystalline array composed of S-layer pro-
teins (SLPs) and related cell wall proteins (8, 9). The major
S-layer proteins, LMWandHMWSLPs, are derived from post-
translational cleavage of an95-kDa precursor, SlpA (10). The
slpA gene is encoded within a genetic locus, termed the S-layer
cassette (SLC), that encodes slpA and the adjacent genes cwp66,
cd2790, and secA2 (Fig. 1) (11). Genetic variation in slpA is
observed and is reflected in amino acid variation in SlpA, par-
ticularly in the LMWSLP, which shows higher sequence diver-
sity than the HMW SLP (10).
Most archaeal species and many bacterial species present an
S-layer on their outer surface (8, 12). S-layers are composed
primarily of a single species of (glyco)protein covering the
entire surface of the cell and present as a two-dimensional array
(12, 13). No single function has been described for S-layers;
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rather a diversity of sequences is found that appear to accom-
modate a wide range of functions ranging from a selectivity
barrier through various roles in pathogenesis (8, 14). In C. dif-
ficile, the S-layer protein SlpA is recognized by TLR4 on
immune cells and may be a primary factor for the immune
system to recognize and respond toC. difficile infection (15). In
Bacillus anthracis, the functions of the primary S-layer proteins
are unknown, but minor S-layer proteins can function in adhe-
sion to host cells or uptake of iron and have been shown to be
essential for full virulence of the bacterium (16, 17). Structur-
ally, S-layer proteins are found to be diverse, although the
three-dimensional crystal structures of only a few have been
determined (18–24). Many S-layer proteins are composed of
two domains: one domain anchored to the underlying cell wall
and forming the two-dimensional array, and the second
domain being surface-exposed and thus suitable for mediating
function. In B. anthracis and some other species, a pyruvylated
secondary cell wall polysaccharide serves as the anchor for the
S-layer proteins Sap and EA1 (25), but in C. difficile the S-layer
is noncovalently anchored to the secondary cell wall polysac-
charide PSII (26).
Some S-layers carry large, surface-exposed glycans (27–29).
Glycans are normally O-linked to the S-layer protein in bacte-
rial species but can be O- or N-linked in archaea. The sugars
found on these glycosylated S-layer proteins can be unusual and
not found in eukaryotes (29).Where studied, species expressing
glycosylated S-layers contain a gene locus specifying the syn-
thesis of the glycan chain, its export through the membrane(s),
and ligation to the S-layer protein (27, 29). Glycosylation has
been observed at one or several residues on S-layer proteins
from several species, e.g. Geobacillus stearothermophilus and
Paenibacillus alvei (27) In these cases, the glycan and the
S-layer protein are not co-translocated but are exported inde-
pendently across the cell wall through separate mechanisms,
and it is likely this is true for many other species with glycosy-
lated S-layers (29).
In a genomics study of over 1000C. difficile strains, variation
in C. difficile SLCs was observed, and 13 SLC types (SLCTs)
were identified, each encoding a distinct SlpA protein (11). One
cassette type (SLCT-11) was found to contain a large 24-kb
insertion that encoded a putative glycosylation locus. In
SLCT-11 strains, this locus is located downstream of secA2,
with its insertion causing a rearrangement of cwp66 and cd2790
and loss of cwp2 (Fig. 1). The genes contained within this locus
resemble most closely those present in other Gram-positive
species that produce glycosylated S-layers, for example G.
stearothermophilus and P. alvei (27). In the former species, the
glycosylation gene cluster is located immediately downstream
of the S-layer gene, sgsE, but in P. alvei the S-layer gene is
unlinked.
In this study, we analyze the S-layer structure of the C. diffi-
cile SLCT-11 strainOx247 and show conclusively that the SlpA
is modified by a large glycan whose composition and structure
are determined. The roles of key genes are defined by deletion
analysis, and the phenotypes associated with glycosylation are
investigated.
Results
Genetic analysis of the Ox247 glycosylation locus
The majority of C. difficile strains lack a genetic locus that
could encode the machinery for glycosylation of surface pro-
teins. An exception is SLCT-11 strains that contain a 24-kb
gene cluster indicative of glycosylation of surface proteins (11).
The putative glycosylation locus of SLCT-11 strain Ox247 is
illustrated in Fig. 1. Bioinformatics analysis (Table S1) pre-
dicted 20 genes, including those encoding an initiating glyco-
syltransferase (orf2), several glycosyltransferases (orfs 3, 6–10,
and 18), an ABC transporter that could potentially transport a
glycan to the exterior surface of the cell (orfs 11 and 12), a
dTDP-L-rhamnose biosynthetic pathway (orfs 13, 14, 16, and
17), and a protein ligase (orf19). Many of these genes have ho-
mology to biosynthetic pathways that synthesize, transport,
and ligate glycans to S-layer proteins in Gram-positive or
Gram-negative species (11). The 20 ORFs within the glycosyl-
ation locus are transcribed as a polycistronic operon with the
adjacent genes CD2790 (downstream) and cwp66 (upstream)
(data not shown).
To investigate whether this locus was involved in modifi-
cation of the S-layer, mutants were constructed in Ox247 using
the ClosTron mutagenesis system that inactivates genes
through targeted insertion of an antibiotic resistance cassette
(30). The orf2, orf3, orf4, orf7, orf16, and orf19 genes were
mutated in this way using an erythromycin resistance marker.
S-layer proteins from Ox247 and the mutants were prepared
and analyzed by SDS-PAGE (Fig. 2).
Figure 1. C. difficile S-layer and glycosylation genetic loci. The S-layer loci of strains 630 (A) andOx247 (B) show the relative locations of slpA and surround-
inggenes. Insertionof a 24-kb locusharboringaputativeglycosylationmachinery is shown inOx247and inmoredetail inC. TheORFsof theglycosylation locus
in C are numbered according to Ref. 11 and are color-coded to indicate putative function: green, glycosyltransferases; purple, glycosyltransferases; red, ABC
transporter; pink, rhamnose biosynthesis; orange, oligosaccharide ligase;white, no function predicted.
S-layer glycosylation in Clostridium difficile
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S-layer proteins from WT Ox247 can be compared with
those from 630, a well characterized C. difficile strain. In con-
trast to the two predominant SLPs seen in 630, migrating at
43 kDa (HMW SLP) and 35 kDa (LMW SLP), only one
highly stained band is seen in Ox247, migrating at 42 kDa
(Fig. 2). A number ofminor bands were also evident both above
and below the 42-kDa band in Ox247. Sequence analysis of
Ox247 SlpA predicts two SLPs formed from the cleavage of the
mature SlpA protein, a HMWSLP of45 kDa and a LMWSLP
of 20 kDa. The size of the LMW SLP is considerably smaller
than those observed and predicted in other C. difficile strains.
However, this 20-kDa species is clearly absent from the WT
Ox247 S-layer extract.
In contrast, all mutants (orf2, orf3, orf4, orf7, orf16, and orf19)
produced a band at20 kDa, which was shown byMS to be the
LMW SLP (see below). This strongly suggests that the genetic
locus does indeed encode a glycosylation pathway thatmodifies
SlpA and that disruption of the pathway results in the appear-
ance of the predicted20-kDa LMW SLP. Comparison of the
banding pattern of Ox247, the orf2 mutant, and the mutant
complemented by a plasmid expressing Orf2 reveals a lack of
several high-molecular-weight bands above the HMW SLP
(44 kDa) in the mutant. These bands were predicted to con-
tain glycosylated forms of the 20-kDa LMW SLP. Comple-
mentation of the mutants was either complete, restoring the
WT banding pattern (orf2 and orf3), or incomplete (orf16 and
orf19), orwas not possible (orf7) due to the inability to construct
a stable plasmid in Escherichia coli.
Discovery of complex S-layer glycosylation: Glycoproteomic
and glycomicMS analyses
Unequivocal evidence for glycosylation of the S-layer was
determined by glycoproteomic mass spectrometric strategies
applied to the analyses of the S-layer proteins (31–34). S-layer
extracts fromWTandmutants were purified by gel electropho-
resis, in-gel digested with trypsin, and analyzed by nano-LC
coupled to electrosprayMS (35–38).MS data on signals eluting
between 37 and 40min for the band at 42 kDa fromWTOx247
(Fig. 3) showed an interesting pattern of doubly charged ions,
starting at m/z 878 (the signal at m/z 911.9 derives from a dif-
ferent peptide), separated from other prominent signals by
intervals corresponding to sugars (m/z 81 for hexose (Hex),m/z
73 for deoxyhexose (dHex), andm/z 66 for pentose (Pent)). The
series can be interpreted as beginning with the tryptic peptide
atm/z 878 and extending by a hexose tom/z 959, by cleavage at
the glycosidic bond with hydrogen rearrangement and charge
retention on the reducing end fragment, followed by four dHex
intervals (tom/z 1032, 1105, 1178, and 1251). Following them/z
1251 signal, the pattern then deviates with two possible cleav-
age fragments, which indicates branching. The next increment
is Pent tom/z 1317 or dHex to 1324. A common phenomenon
in the MS/MS of branched saccharides is the -elimination of
side chains, sometimes giving the strongest signals not at the
branching point itself, but at later cleavages. The sugar series
then continues fromm/z 1324 with a further hexose residue to
m/z 1405, but this signal is also a pentose difference from m/z
1471. This spectrum therefore affords two possible interpreta-
tions, either with a pentose branch at them/z 1251 (4th dHex)
cleavage position to give an overall m/z of 1317, or at the Hex
m/z 1471 position to give m/z 1405 by -elimination of the
pentose. Them/z 1317 is a crucial signal here, in that it cannot
easily be rationalizedmechanistically as deriving from the latter
(Hex–Pent) possible branching series, although it can be inter-
preted as locating the branching point on the fourth dHex from
the reducing end of the structure, with Pent loss to 1251 (see
Fig. 3).m/z 1324 is then seen to derive from pentose loss from
the signal at 1390 in Fig. 3. This branching substitution is sug-
gested and proven by the NMR study (see below), and the over-
all assignment of the glycopeptide MS/MS spectrum in Fig. 3
shows that the oligosaccharide chain continues out to higher
mass (no nonreducing end capping observed) via signals atm/z
1478, 1544, 1617, 1690 1771, and 1837 (assignments shown in
Fig. 3 schematic) giving a minimal length for this novel oligo-
saccharide glycoprotein conjugate of 13 sugar residues at a sin-
gle point of peptideO-linked substitution. The doubly-charged
fragment ion at m/z 878 itself, together with its subfragments,
established this as a peptide with the sequence DILAAQNLT-
TGAVILNK, which corresponds to residues 29–45 of the low-
molecular-weight subunit of the S-layer protein. Other ions in
the above series selected forMS/MSanalysis by thedata-depen-
dent software at this time point in the LC-MS trace were the
m/z 959, 1032, 1105, and 1178 glycopeptide fragment signals,
and those data also confirmed the sequence conclusions shown
in Fig. 3.
To investigate the biosynthesis of this unique type of glyco-
peptide found in the WT sample, the S-layers of the orf2, orf3,
and orf7 mutants were subjected to the same glycoproteomic
strategy. All gave gel bands near 20 kDa (Fig. 2). In the case of
the orf2mutant, this bandwas found to contain the unmodified
LMWSLP.The bands near 20 kDa from the othermutantswere
found to contain glycosylated LMW SLP. The glycan chains
ranged in size from two sugar units, specifically dHexHex (orf3
mutant), up to a heptasaccharide Pentd-Hex5Hex seen in the
orf7mutant (Fig. S1, A and B).
To gain a better understanding of what was clearly a larger
structure than shown by the electrospray MS andMS/MS data
in Fig. 3, full profiling of the S-layer glycoprotein using a more
comprehensive range of MS techniques was employed (i) to
define the precise site of attachment of the glycan chain to the
Figure 2. S-layer proteins of C. difficile Ox247 and mutants. Strains were
cultured in BHIS broth, and the S-layer was prepared using low pH glycine
extraction. The LMW (”) and HMW (–) S-layer proteins of strain 630 are indi-
cated. The 20-kDa LMW SLP (3) predicted in Ox247 is not found in the WT
strain, but is found in some but not all mutants. The45-kDa bands in Ox247
analyzedbyMSare indicated (**).M,Mrmarkers; lane 1, 630; lane 2, Ox247WT;
lane 3, orf2::erm; lane 4, orf2::erm (pAAM008); lane 5, orf3::erm; lane 6, orf2::erm
(pEJR004); lane 7, orf4::erm; lane 8, orf4::erm (pEJR007); lane 9, orf7::erm; lane
10, orf16::erm lane 11, orf16::erm (pEFR009); lane 12, orf19::erm; and lane 13,
orf19::erm (pAAM011).
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S-layer proteins, (ii) to determine the carbohydrate composi-
tion and linkage of the glycan moieties observed in the MS/MS
as Hex, dHex, and Pent, and (iii) to determine the overall size
and sequence of the novel oligosaccharide component of this
glycoconjugate. The S-layer glycoprotein sample was therefore
prepared for study using different strategies and a range of
analytical MS techniques, including GC-MS, MALDI-TOF
MS, MS/MS, Q-TOF ES-MS, and MS/MS, also incorporat-
ing electron transfer dissociation (ETD) (39), as well as elim-
ination, chemical derivatization, and GC-MS methods fol-
lowing hydrolysis.
Site of attachment—The ETDMS/MS spectrum of the glyco-
peptide [M  4H]4 (m/z 516.55) at 25 min, belonging to the
20-kDa band of the orf3 mutant, is shown in Fig. 4. From this
spectrum, there is excellent evidence for the substitution of
dHexHex on Thr-38 of the sequence determined, supported by
several fragment ions. First, considering the “c” series, there is
no signal atm/z 1265 (c9 dHexHex), butm/z 957 (free c9) is
strong, and there is a strong peak atm/z 1366 that corresponds
to c10  dHexHex (1058  146  162). Second, coming from
the C terminus of the peptide, the free z8 fragment ion is absent
(m/z 798), but the glycosylated signal is seen atm/z 1107 (z8
1 dHexHex) (Fig. 4).
Sugar composition and linkage—We next examined the
O-linked glycan chain decorating the LMW SLP of C. difficile
Ox247 via GC-MS to attempt to determine the sugar composi-
tion and, if possible, the linkages. WT Ox247 S-layer protein
was extracted and purified by dialysis, reductively eliminated,
and hydrolyzed into monosaccharides. Alditol acetate deriva-
tives of the samples were then prepared and analyzed by GC-
EI-MS and assigned by comparison with standards, using the
GC retention times as well as the specific MS fragmentation
patterns of each monosaccharide found (40). From these data,
the O-glycan of the S-layer glycoprotein was found to contain
principally rhamnose, with lesser amounts of ribose, glucose,
and a small amount of galactose (Fig. S2). For a complex natural
product, such as that found here for the S-layer glycan ofC. dif-
ficileOx247, containing amixture of related polymeric compo-
nents ranging up to approximately 50 sugar residues or more
(see below), it was not thought useful to make quantitative cal-
culations of relative ratios. An attempt was then made to carry
out linkage analysis on the -eliminated oligosaccharide,
following permethylation, by the standard hydrolysis and re-
acetylationmethod to produce partially methylated alditol ace-
tate. Examination of themass spectra of each peak eluting from
the GC column permitted assignment by comparison with the
publicly available database on the Complex Carbohydrate
Research Center website (University of Georgia, Atlanta).
Positive assignments were possible for terminal ribose,
3-linked rhamnose, 3,4-linked rhamnose, and 4-linked glu-
cose (data not shown), although other unassigned small sig-
nals were also observed.
The data support the basic structural conclusions in the MS
data set of Fig. 3 regarding the presence of hexose (mainly Glc
but also Gal), deoxyhexose (only rhamnose), and pentose (only
ribose) units in the oligosaccharide, including the facile loss of
terminal pentose-branching units, but apart from the presence
of someweak noninterpreted peaks, therewere no further clues
Figure3. Patternofdoubly-charged ionsobserved in the trypticdigestQ-TOFLC-ES-MSdata set showing in-source fragmentationof aglycopeptide,
thepeptide componentofwhich is observedat 878.02.Doubly charged ions corresponding to sugarmass intervals linked to this peptide are shown in the
cartoon above the spectrum. These data showevidence for aminimumoligosaccharide substitution of 11 residues and a sequence (starting from the reducing
(peptide-attached) end) of Hex-dHex-dHex-dHex-dHex(Pent)-dHex-Hex-dHex-dHex(Pent). See the text for details of the assignments.
S-layer glycosylation in Clostridium difficile
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in the composition and linkage data as to the missing unit(s)
needed to identify the nonreducing end structure.
Mass and sequence of the oligosaccharide—Having discov-
ered a novel long–chain O-linked oligosaccharide on LMW
SLP together with its precise site of attachment in the protein
sequence, the objective was then to define the size of this
unusual structure, including its nonreducing end and overall
sequence, and for this purpose the oligosaccharide was first
removed from the protein backbone by -elimination. The
sample was then derivatized by permethylation to allow exam-
ination byMALDI-TOFMS andMS/MS (41, 42). Interestingly,
and surprisingly, in the MS spectrum coming from the 75%
acetonitrile fraction of theWT sample acquired using theTOF/
TOF instrument in linearMSmode (Fig. 5A), it is possible to see
that the glycan chain decorating the S-layer protein of C. diffi-
cile Ox247 is much longer than the electrospray (ES-MS) data
had indicated (in Fig. 3), probably due to the very low internal
energy transfer associated with MALDI ionization preserving
the highermass structures. In fact, from theMALDI data in Fig.
5A there is evidence of a long glycan chain of the order of 50
sugar residues, with abundant high-mass signals around m/z
6744 and 7632, but with the highest readily visible peak atm/z
8520 (peak top), withweaker highermass signals indicating that
even that is not the limit of the structure of this molecule. Note
also the weak satellite signals 160 Da lower and higher than the
main ones, possibly indicating some heterogeneity with species
lacking a ribose or carrying an additional one, because ribose
has this mass difference when permethylated. Overall, these
MS data illustrate a repeating pentasaccharide unit of mass 886
Da, corresponding to a permethylated [HexRha3Rib]n compo-
sition where the repeat number “n” varies, leading to different
polymer lengths.
Several MS/MS experiments were then carried out by
MALDI TOF/TOF with refined mass calibration to define the
sequence, and in these spectra the presence of certain “starting
numbers” and fragment ion series are clear, as seen for 6744 in
Fig. 5B. For example, in the lowmass range of the spectrum, the
ion atm/z 1509 is themore abundant fragment and is separated
fromm/z 1305 by 204 atomic mass units (a permethylated Glc
or Gal mass difference), which in turn is separated from m/z
1131 by 174 atomic mass units (a Rha difference) below that.
These data, combined with knowledge of sugar fragmentation
mechanisms and the fact that MALDI ionization of permethy-
lated oligosaccharides under these conditions produces M 
Na quasi-molecular ions, together also with the fact that the
elimination strategy used to free the oligosaccharide from the
peptide backbone leads to the production of an open-ring
reducing-end residue, then allowed a test calculation to deter-
mine whether these signals came from the nonreducing or the
reducing endof the overallmolecular structure. In thisway,m/z
Figure 4. ETDMS/MS spectrum ofm/z 516.554 derived from the C. difficile orf3::ermmutant. Peptide fragmentation provides strong evidence for the
sequenceDILAAQNLTTGAVILNK. c-ions are labeled inorange and z-ions inpurple. Following the knownETDmechanism, the cleavageof theN–Cbondoccurs
producing C-type (N-terminal) and Z-type (C-terminal) fragments. Themass difference between two adjacent c or z ions provides themass and identity of the
amino acid residue and any substitution, which here identifies the glycan as being attached to threonine 38 (see the text).
S-layer glycosylation in Clostridium difficile
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1509 could be assigned to a reduced and sodiated Glc/Galred–
Rha5–Rib–Glc/Gal fragment ion, showing that (a) it is the
reducing end fragment (attached originally to the peptide via
the hexose) and (b) it corresponds to the first 8 residues of the
13-residue structure discovered in the Q-TOF ES-MS/MS
experiment seen in Fig. 3, which was assigned as the branched
structure Hex–dHex–dHex–dHex–dHex(Pent)-dHex–Hex-
dHe-x-dHex(Pent)–dHex-Hex. Continuing the interpretation
of the MS/MS spectrum in Fig. 5B from the m/z 1509 ion
toward higher mass, a series of signals are found between that
and the nextmost abundant fragment atm/z 2395, correspond-
ing to a mass difference of 886.4 Da via m/z 1683, 2017, and
2191 assigned to a sequence of Rha-Rha(Rib)–Rha–Glc/Gal.
This pentasaccharide pattern, created by a cleavage between
Rha and Glc (the most abundant hexose in the compositional
analysis), which would appear to be a preferred fragmentation
pathway, then continues in further increments of 886mass unit
increments to m/z 3282, m/z 4171, and m/z 5057 generating a
polymer chain for this particular parent ionmass (6744 in linear
MS mode). Note that the mass sufficiency and predominant
isotope “peak top” labeled by the instrument software, which is
often several mass units higher than 12C,must be accounted for
in the mass annotations observed in such spectra at higher
masses. From these data, and the MS/MS analysis of other sig-
nificantly strong signals in the MALDI MS spectrum, which
themselves differ by this 886 repeating sugar units, it is clear
that the novel oligosaccharide discovered here is in fact a series
of closely related repeat polymer structures spanning a consid-
erable mass range, beyond 5000 Da.
Turning to the quasi-molecular ion region of the MS/MS
spectrum in Fig. 5B, where the “peak top” mass of the quasi-
molecular ion (M  Na) is corrected to 6736 Da, the losses
observed do not fit for the now-established reducing-end struc-
ture andmust therefore be coming from the unknown structure
at the nonreducing end of the molecule. Auto-peak labeling at
these very high masses depends on small fluctuations in 13C
isotope abundances, but averaging the data from this parent ion
(6736) and the MS/MS spectrum of the next higher polymer in
the series shows that the losses seen are principally 255 (to
6481), 283 (to 6453), and 589 (to 6147), where the 28-a-
tomicmass unit difference between the 6481 and 6453 could be
assigned to a probable ring cleavage counterpart (containing
C-1 and the ring oxygen atoms of the terminal sugar) to the
glycosidic bond cleavage expected for m/z 6453. These losses
were not interpretable on the basis of the standard sugars found
in the composition analysis, and therefore the nonreducing end
Figure 5. A, MALDI-TOF MS spectrum from m/z 5000 to 10,000 of the permethylated glycan isolated from the S-layer protein of C. difficile Ox247. The data
provide strong evidence for the presence of a long glycan chain of some 50 sugar residues, containing a repeating pentasaccharide unit of 886 Da within its
structure (highlighted in red), corresponding toaGlcRha3Rib composition, and leading todifferentpolymer lengths. Fordetails see the text.B,MALDI TOF/TOF
MS/MS spectrum fromm/z 9 to 7122 of the signal centered aroundm/z 6744 in Awhich in the calibrated MS/MS spectrum is appearing with a peak-topmass
of 6736. Differences of hexose, deoxyhexose, and pentose are visible throughout the spectrum, and the sequence can be built up from the reducing end
fragment (corresponding to the peptide-attached oligosaccharide sequence determined from the ES-MS data in Fig. 3) as described in the text to the Rha-Glc
cleavage atm/z 1509. From there, intervals of a repeating pentasaccharide sequence (886 Da) are clearly determined tom/z 2395 and higher masses toward
thenonreducingendof the structure. Except for unassigned losses from themolecular ion, the reducingendmoiety remainedelusive at this stageof the study.
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group could not be assigned from the MS data alone. To
characterize the precise nature of the nonreducing end moi-
ety, and to specify the absolute stereochemistry and linkages
of the oligosaccharide, the structure was then examined by
NMR spectroscopy.
NMR analysis of S-layer glycan
To obtain sufficient SLP glycan for NMR analysis, 36 mg of
SLP protein was extracted from bacterial cells using glycine
buffer (43). The SLP protein extracts were extensively digested
with proteinase K for 48 h, and small nonglycosylated peptide
fragments were removed using Amicon filtration (3000 Da cut-
off). Digested material, which was retained in the supernatant
(3000Da), was collected and lyophilized. Further purification
of this larger molecular weight, soluble material was made by
applying the sample to aHitrapQ anion-exchange column, and
fractions were eluted with 0–1 M gradient of NaCl. Fractions
were desalted on Sephadex 15, and glycan-containing frac-
tions were identified by 1H NMR. Two glycan-containing frac-
tions were obtained, one fraction eluted in water at the begin-
ning of the NaCl gradient (PS-1), and a second fraction eluted
later in0.2 M NaCl (PS-2).
2D NMR spectra (COSY, TOCSY, ROESY, 1H–13C HSQC,
1H–13C HMBC, 1H–31P HMQC) were recorded for PS-1 and
PS-2. PS-1 was identical to a previously studiedC. difficile poly-
saccharide (PSII) (data not shown) (44). The second glycan was
of unique structure with pentasaccharide repeating units and
distinct fragments at both reducing and nonreducing ends.
NMR signals were completely assigned for PS-1 (data not
shown) and PS-2 (Table 1 and Fig. 6A). Monosaccharides were
identified by COSY, TOCSY, and NOE spectroscopy cross-
peak patterns and 13C NMR chemical shifts. Connections
between monosaccharides were determined from transglyco-
sidic NOE and HMBC correlations. For PS-2, the following
NOE correlations from H-1 of the monosaccharides were
observed: A1, M1,2,3; A1, M2,3; B1, L1,2,3; B1, M6; C1, D3;
D1, E3; E1, N3; K1, M4,6; F1, B2,3,4; M1, F4,6; M1, F4,6; M1,
C4; L1, M4,6; N1, Thr*3. HMBC correlations were in agree-
ment withNOE data: A1,M3; A1M3; A1M3; B1, L3; C1, D3;
D1, E3; E1, N3; K1, M4; F1, B4; L1, M4; M1, F4; M1, F4; M1,
C4; N1, Thr-3. These observations allowed the assembly of the
structure presented in Fig. 6B.
For PS-2, signals from the internal repeating units as well as
reducing and nonreducing ends of the polymer were visible.
The reducing end was occupied by a tetrapeptide containing
Ala, Gly, and two Thr residues. The reducing end sequence of
monosaccharides -3--Rha-3--Rha-3--Gal- was different
from that of the repeating units. Terminal Gal was linked to one
of the Thr residues of the peptide, as assignable from NOE and
HMBC data. This is a typical O-linkage of glycan to protein in
S-layer proteins.
The nonreducing end of this unique glycan was occupied by
a-Rha residueK. Thismonosaccharide had 1H and 13C signals
ofH,C-2,3 strongly shifted to low fieldwhen comparedwith the
expected values for nonsubstituted -Rha (Table 1). The 31P
spectrum contained a signal at 16.2 ppm, correlating in 1H–31P
HSQC to K1 and K3 but not to K2 (Fig. 7). H-3 signal had
additional 18 Hz splitting due to H–P coupling. The nature of
this phosphate remained unclear at this stage; In addition the
10 ppm downfield shift of H-3 signal and the huge coupling
constant with 31P are also difficult to explain. Particularly
intriguing is the correlation H-1–P with no trace of H-2–P cor-
relation. At this point, we were unable to assign a definitive
structure for this phospho-derivatized rhamnose nonreducing
end residue but made a tentative 3-phospho-Rha assignment
(Fig. 6B).
Correlation of themass spectrometry and NMR data
The detection of a phosphate proton resonance in the NMR
then allowed a re-examination of the MALDI MS/MS data to
correlate masses observed with a possible phosphate-substi-
tuted rhamnose nonreducing endmoiety. First, in the interpre-
tation of the data in the quasi-molecular ion region of the per-
methylated sample in Fig. 5B, the loss of 283 mass units to give
m/z 6453 can now be rationalized as the loss of a dimethyl-
phospho-rhamnose terminal unit via glycosidic bond cleavage
with hydrogen transfer.m/z 6481 is the ring-cleavage fragment
retaining H–CO on the reducing end referred to earlier. The
remaining abundant ion in this region at m/z 6147 is then
assigned as the equivalent ring fragment to 6481 at the next
Table 1
NMRdata for the S-layer polysaccharide PS-B (ppm from acetone, 600
MHz, 35 °C)
H/C-1 H/C-2 H/C-3 H/C-4 H/C-5 H/C-6
Ribf A 5.31 4.14 3.99 4.35 3.70; 3.76
99.0 72.5 71.1 86.4 62.6
Ribf A 5.26 4.11 3.97 4.46 3.74; 3.74
99.4 72.6 71.5 86.5 62.6
Ribf A 5.30 4.14 3.99 4.35 3.70; 3.76
99.0 72.5 71.1 86.4 62.6
-Glc B 5.10 3.59 3.93 3.68 4.01 3.80; 3.89
96.5 72.5 73.9 77.9 71.6 61.6
-Rha C 5.06 4.14 3.96 3.62 3.95 1.32
103.3 71.2 70.2 83.8 68.7 17.9
-Rha D 5.04 4.15 3.92 3.56 3.86 1.31
103.3 71.2 79.7 72.5 70.5 17.9
-Rha E 5.03 4.17 3.91 3.58 3.88 1.30
103.3 71.2 79.4 72.5 70.4 17.9
-Rha F 4.90 4.15 3.72 3.54 3.54 1.34
101.9 71.2 72.7 83.7 72.1 17.9
-Rha K 4.97 4.68 4.34 3.62 3.45 1.33
99.6 75.8 81.1 74.1 72.3 17.9
-Rha L 4.77 4.24 3.68 3.44 3.43 1.34
101.0 68.1 78.9 73.5 73.6 17.9
-Rha M 4.76 4.34 3.94 3.74 3.62 1.38
101.4 68.1 75.5 77.8 72.9 18.2
-Rha M 4.78 4.33 3.90 3.80 3.62 1.40
101.4 68.4 75.5 78.2 72.9 18.2
-Rha M 4.77 4.34 3.94 3.74 3.62 1.38
101.4 68.1 75.5 77.8 72.9 18.2
-Gal N 4.56 3.65 3.72 4.03 3.73 3.78; 3.78
102.0 71.3 81.3 69.6 76.3 62.1
Thr* 4.60 4.34 1.29
59.5 75.3 17.0
Thr 4.00 4.22 1.34
59.7 67.3 19.9
Gly 3.98; 3.98
43.8
Ala 4.20 1.33
52.0 18.8
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Figure 6. A, 1H–13C HSQC spectrum of the polysaccharide from S-layer protein SlpA (PS-2). CH signals are black, and CH2 signals are green. B, structure of
PS-2.
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residue, which is assigned as a branched Rha-(Rib), 334-atomic
mass unit difference.
Importantly, this assignment of a terminal Rha-phosphate
moiety (which from sub-fragment data could be positioned at
the 2- or 3-position in the ring) did not correlate with the over-
all mass data coming from both the MALDI MS of permethy-
lated derivatives or from the data on the intact glycopeptide
itself, and this now required explanation. Fig. 9 shows the neg-
ative ion MALDI MS/MS spectrum of the native glycopeptide
isolated by proteinase K digestion in preparing the NMR sam-
ple above. This spectrum was determined by collisionally acti-
vated decomposition of the parent ion observed at m/z 6563.6
(peak top) for the [M  H] species. In arithmetic terms, this
would correspond to a 12Cmass of 6560.6 for the glycopeptide.
Because in other (electrospray) data (not shown) we had defin-
itively assigned the peptide portion of the molecule as the
sequence TTGA (with no ragged ends), the theoretical 12C
mass for the glycopeptide, containing a terminal Rha-phos-
phate and with the repeat unit n  7, is calculated as 6578.4.
Althoughmass accuracy in this difficult type of high-mass neg-
ative ionMS/MS experiment on small amounts of material can
be questionable, within plus or minus a mass unit or so, it is
nevertheless clear that the intact mass data on the native glyco-
peptide does not correlate with a phosphate substitution of the
terminal rhamnose and is roughly 18 mass units lower than the
theoretical mass overall.
Fig. 8 explains the solution to this conundrum, via interpre-
tation of the importantmajor fragment ions atm/z 225 and 631
in the MS/MS spectrum of 6564 [M  H]. m/z 225 actually
provides the evidence for the source of the 18-atomicmass unit
difference between experimental and theoretical masses dis-
cussed above, because it is 18 atomic mass units below what
would be expected for a phosphate-substituted rhamnose resi-
due. This mass was assigned as cyclophospho-rhamnose as
shown in Fig. 8, and the fragment ion itself derives from glyco-
sidic bond cleavage with retention of the glycosidic oxygen and
concomitant hydrogen transfer to that atom from the second
sugar in the chain. The next significant fragment is seen atm/z
631, which is due to cleavage and charge retention on the
nonreducing end again, but is now between a Rha(Rib) and Glc
residue with retention of the glycosidic oxygen on the reducing
end (uncharged) fragmentwith hydrogen transfer from the Rha
to that oxygen. Interestingly, from this point, the principal frag-
ment ions are all due to similar Rha–Glc cleavages along the
oligosaccharide backbone, separated by the repeat pentasac-
charide unit Rha–Rha(Rib)–Rha–Glc to give m/z 1363, 2095,
2829, 3562, and 4295. A single (less favored) reducing end frag-
ment, which corresponds to the partial sequence identified in
Figs. 3 and 6, is observed atm/z 1533 in this spectrum, whereby
the negative charge would most probably reside on the peptide
carboxylate anion. The 6564.6 peak top assignment in the TOF
MS calculates for a 12C value of 6559.6 for [MH] and thus a
molecularmass of 6560.6 for the glycopeptide, which is close to
the theoretical calculated mass for the new structure.
Interestingly, the apparent anomaly of the MALDI TOF/
TOF data on the-eliminated permethylated samples correlat-
ing with a dimethylphosphate-substituted terminal rhamnose
moiety is explained by the chemistry of the permethylation
reaction and its predictable effect on a cyclic phosphate substi-
tution of this type. The rhamnose cyclophosphate would be
subject to nucleophilic attack by hydroxide anion at either of
the sugar ring attachment points (C-2 or C-3), which would
lead to ring opening to produce a linear phosphate substitution
with two hydroxyls for subsequent methylation.
Following the assignment of the overall masses of the oligo-
saccharide polymers, together with the specific nonreducing
terminal mass assignable as corresponding to a possible
cyclophospho-deoxyhexose in the corresponding negative ion
MALDI TOF/TOFMS/MS data in Fig. 8, theNMRdata in Figs.
6A and 7 were re-evaluated for evidence of such a moiety.
Cyclophosphate substituents have been found on some natu-
rally occurring sugars or have been synthesized, and they
appear to be characterized by chemical 31P shifts of 18–29 ppm
and large coupling constants from 12 to 22 Hz. For example,
cyclophosphate at positions 1,2 of mannose demonstrated a
chemical shift of 19.7 ppm (45), whereasmethyl-L-glycero--D-
manno-heptopyranoside-6,7-cyclophosphate had a 31P chemi-
cal shift of 18.3 ppm (46). The 16 ppm chemical shift and 18 Hz
coupling observed in the S-layer structure are within these
ranges and allow an assignment of a 2,3 cyclophosphate on the
terminal rhamnose residue Lys. The overall structure of the
glycan attached to SlpA predicted from theNMRandMS inter-
pretations is depicted in Fig. 9.
Figure 7. 1H–31P HSQC spectrum of PS-2.
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Phenotypes of glycosylation-defectivemutants
To investigate the functional relevance of S-layer glycosyla-
tion, a variety of experiments were carried out on the physiol-
ogy and behavior of C. difficile Ox247 compared with mutants
in the glycosylation locus.
Ox247 and mutants in orf2, orf3, orf4, orf7, orf16, and orf19
grew normally and did not exhibit any growth defect in liquid
media (data not shown). However, we noticed that the cells of
every mutant were shorter than the WT (Fig. 10). The average
cell of WT Ox247 cells was 6.52 m, with the mutants having
average lengths of 5.34 m (orf2), 5.79 m (orf3), 5.56 m
(orf4), 5.68 m (orf7), 5.75 m (orf16), and 5.14 m (orf19). In
all mutants (except orf7 where complementation was not pos-
sible), the cell-length defect in the mutant was complemented
by a plasmid expressing the WT gene, with a significant (p 	
0.001) increase in mean cell length occurring (Fig. 10B and Fig.
S4, A–D).
A key phenotype of the Clostridium genus is the ability to
differentiate to form heat-resistant spores (4). We found that
although Ox247 produced spores at a normal rate, the orf2 and
orf19 mutants were deficient in this process (Fig. 11). After
120 h in liquid culture, Ox247 produced 106 spores/ml. In
contrast, theOx247 orf2mutant produced no detectable spores
at all during this period. Interestingly, the orf2mutant contain-
ing the WT orf2 gene behaved similarly to the orf2 mutant,
producing no spores, despite this strain being able to comple-
ment the S-layer cell wall protein phenotype as determined by
SDS-PAGE (Fig. 2). The sporulation-defective phenotype could
not be complemented by plasmids expressing orf2 from either a
constitutive promoter (Pcwp; Fig. 11C) or from the anhydrotet-
racycline-inducible promoter, Ptet (data not shown).
Several studies have implicated the S-layer of C. difficile to
play a key role in its adhesion to host intestinal cells (47, 48). To
investigate whether glycosylation of the S-layer affects adhe-
sion to intestinal cells, adhesion of Ox247 and the orf2mutant
to intestinal Caco-2 cells was compared. As shown in Fig. 12,
adhesion was greater in Ox247 compared with its orf2 mutant
Figure 8. Negative ion MALDI TOF/TOFMS/MS spectrum of the native glycopeptide of Ox247 isolated by proteinase K digestion. The data show the
detailed fragmentation produced from a quasi-molecular ion signal found in the MS spectrum at (peak-top)m/z 6563.6, and clearly identify (i) a nonreducing
end structure 18mass units below that expected for phospho-rhamnose and (ii) an intactmass some 18 atomicmass units lower than expected for the overall
predicted structure in Fig. 7. These data suggest a cyclophospho-rhamnose nonreducing terminus. For detailed interpretation see the fragmentation cartoon
above the spectrum and the text.
Figure 9. Deduced overall structure of the glycan attached to SlpA in
Ox247 fromMSandNMRdata. The structure contains8 copies of a repeat
containing Rha, Glc, and Ribf attached via a linker containing Rha andGal and
attached via an O-linkage to Thr-38 of SlpA. The identity of the capping resi-
due is 2,3 cyclophosphoryl-rhamnose. The genes identified as expressing
enzymes mediating steps in the pathway are indicated.
Figure 10. S-layer glycosylation affects cell length. Box and whisker plots
of cell lengthofOx247 andS-layer glycosylationmutants are shown.A,Ox247
and mutants. B, Ox247, its orf2 mutant and the orf2 mutant containing
pAAM008 expressing WT orf2 gene. Strains were grown overnight in BHI
broth, and cell lengths were measured from phase-contrast micrographs of
450 cells per strain, using ImageJ. Analysis of variance revealed a statistically
significant difference between Ox247 and all mutants (***, p	 0.001). Com-
plementation of the mutants in orf3, orf4, orf16, and orf19 is shown in Fig. S4,
A–D. The Ox247 and orf2::erm data points in A are reused in B, because the
data were acquired from the same experiment.
S-layer glycosylation in Clostridium difficile
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cells. A slight restoration in adhesion was observed by the
Ox247 orf2::erm mutant when complemented with pAAM008
expressing Orf2, but this was not statistically significant. Addi-
tionally, we assessed the effect of S-layer glycosylation on the
ability to form biofilms. A small but significant increase in bio-
film formation was observed in the orf2 mutant that lacks the
glycosylated S-layer (Fig. 12, B and C).
Several studies have implicated cell-surface components in
the cellular behavior ofC. difficile. For example, overexpression
of the cell wall protein CwpV induces aggregation of cells (28),
as does increasing the intracellular level of cyclic di-GMP (29).
We saw no difference between Ox247 and any of the S-layer
glycosylation mutants in aggregation or in flagellar-mediated
motility (data not shown).
Discussion
C. difficile is an important bacterial pathogen that presents
major healthcare problems around the world (1, 2). Pathogenic
strains produce toxins that are the major virulence factors, but
cell-surface components are involved in survival in vivo and in
the transition between a sessile and motile life and between
planktonic and biofilm growth. TheC. difficile S-layer is known
to vary between strains, with at least 13 SLCTs identified to date
(11, 49). Recently, a promising family of novel antimicrobials,
diffocins, have been described that have high activity against
C. difficile (50). Diffocins, which are derived from phage tails,
are highly specific for certain C. difficile strains and have been
shown to target specifically the C. difficile S-layer protein SlpA
(49). The discovery that SLCT-11 is glycosylated could have
important consequences for the use of diffocins to effectively
target the S-layer.
Our study reveals that the S-layer protein of SLCT-11 strains
is unique in being a glycoprotein displaying a complex glycan
on its surface. The organizational structure of the glycan bears
some resemblance to previously described glycans in Gram-
positive bacteria (29).MS andNMR analysis revealed the struc-
Figure 11. Sporulation is compromised in glycosylation-deficient mutants. Overnight cultures of Ox247 (A), Ox247 orf2::erm (B), Ox247 orf2::erm
(PAAM008) (C), and R20291 (D) were grown in BHIS broth, and sub-cultured three times. After the final sub-culture (time 0), sampleswere taken and assayed
for total cells and spores. The R20291 culture was included as a reference to a well-characterized strain. Date are the average
 S.E.
Figure 12. Adhesion andbiofilm formationofC. difficileOx247.A, adhesion to Caco2 cells. Caco2 cellmonolayerswere infectedwithC. difficile strainswith
a multiplicity of infection of 5 and incubated for 2 h. After washing, the viable adherent bacteria were measured by growth on BHIS agar. Data are represen-
tative of seven individual assays, and the S.E. is shown. ***, p	 0.001when comparedwithOx247. B andC,biofilm formation ofOx247 and the orf2mutantwas
assessed at 24 h (B) and 72 h (C). *, p	 0.05.
S-layer glycosylation in Clostridium difficile
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ture of the glycan and showed that it is composed of three
domains: (i) a core tetrasaccharidewith the sequence -4--Rha-
3--Rha-3--Rha-3--Gal-; (ii) a repeating pentasaccharide
with the sequence -4--Rha-4--Glc-3--Rha-4- (-Rib-3-)-
Rha-; and (iii) a terminal 2,3 cyclophosphoryl-rhamnose
attached to a ribose-branched sub-terminal rhamnose. The
overall mass of the glycan identified by MS suggests the pres-
ence of at least8 repeat units linked in tandemand attached at
the reducing end to the tetrasaccharide core that isO-linked to
Thr-38 in the SlpA protein (Fig. 9.) Thr-38 is present within the
LMWSLP of the S-layer protein, which is located on the exter-
nal face of the S-layer, whereas the HMWSLP is located on the
inner face of the S-layer and is in contact with the underlying
polysaccharide–peptidoglycan layer (26).
Our genetic analysis combined with bioinformatics analysis
andMS has cast light on the functions of several of the genes in
the glycosylation cluster. The orf2 mutants fail to synthesize a
glycan as evidenced by the presence of the 20-kDa form of
LMW SLP and the lack of higher molecular weight proteins
migrating at45 kDa. Consistent with bioinformatic analysis,
Orf2 is predicted to be a undecaprenyl phosphate galactose
phosphotransferase that would transfer galactose to undeca-
prenyl phosphate on the inner face of the cytoplasmic mem-
brane. A similar phenotype is seen with orf19mutants, consis-
tent with its role as a ligase, acting on the external face of the
membrane to transfer the complete glycan chain to the S-layer
at position Thr-38. The orf3mutants produce an S-layer with a
truncated glycan, containing dHex-Hex as visualized by MS
and confirmed by NMR analysis of theWT glycan to be -Rha-
3--Gal. Thus, Orf 3 is predicted to be a 1,3-rhamnose rham-
nosyltransferase responsible for the addition of 1–3 rhamnose
residues to the core reducing end tetrasaccharide glycan. MS
analysis of the orf4 mutant showed glycans that consistently
lacked ribose, pointing to this protein being a 1,3-ribosyltrans-
ferase, transferring the Ribf to the Rha (Fig. S5). Finally orf7
mutants produced a truncated oligosaccharide, containing
pentose dHex5Hex. This suggests that Orf7 may be a glycosyl-
transferase that attaches glucose to the rhamnose in the repeat-
ing structure of the glycan.
The machinery described here for synthesis, assembly, and
transport of the glycan and its ligation to the S-layer protein
most resembles those described for glycosylation of S-layers
from G. stearothermophilus and P. alvei (27, 29). The glycan is
built on the cytoplasmic side of the membrane using endoge-
nous undecaprenyl phosphate as an acceptor, first by addition
of a core tetrasaccharide, followed by addition of repeating
polysaccharide, and finally a capping moiety that presumably
terminates synthesis. The glycan is exported via a two-compo-
nent ABC transporter and ligated to the protein on the external
surface of the cell. Termination of glycan synthesis in the sys-
tem we describe here appears to involve incorporation of a
modified phosphate group on the nonreducing end of the cap-
ping group. Phosphate was identified at the nonreducing end of
the O9 O-polysaccharide of E. coli and is required for termina-
tion of glycan chain elongation and for subsequent export via
the ABC transporter (51). To our knowledge, the presence of
phosphate as a constituent of the terminal group of an S-layer
glycan has not previously been described, andwe speculate that
this moiety serves a similar purpose to that in O9a polysaccha-
ride biosynthesis.
C. difficile strains can glycosylate other surface structures,
notably flagella, by addition of O-linked glycans. In some
strains, exemplified by strain 630, a phosphorylated N-methyl-
L-threonine–substituted GlcNAc is present. In ribotype 027
strains, a distinctive modification is found consisting of a novel
sulfonated peptidylamido-glycan containing rhamnose resi-
dues (52).
Approximately 10–15% of C. difficile strains carry SLCT-11,
including the genes that compose the glycan biosynthetic
machinery (11), and therefore they are expected to display the
glycan we describe here. Our previous study showed that other
strains of C. difficile do not contain a glycosylated S-layer, con-
sistent with their lack of glycosylation machinery (53). These
nonglycosylated strains were of ribotypes 001, 012, 010, 016,
017, 027, and 053. However, because the S-layer cassette is
thought to recombine by homologous recombination, there is
not an absolute association of SLCT with ribotype. The strain
we have described here, Ox247, is of ribotype 005 and is within
clade 1. However, further analysis of strains within clade 3 has
revealed a predominance of strains with SLCT-11,9 suggesting
that this glycosylated S-layer does to some extent associate
more stably with some strains than others.
Analysis of mutants defective in glycosylation of SlpA
revealed some interesting phenotypes, suggesting a possible
role for the glycan in the fitness and physiology of C. difficile.
Glycan-negative strains were consistently unable to form
spores, suggesting a role for the S-layer in sporulation. Glycan-
deficient cells were also shorter thanWT cells suggesting a link
between cell division or cell architecture and the presence of a
complete S-layer. Glycan-deficient cells were also less profi-
cient at adhering to the intestinal Caco2 cell line, suggesting the
glycanmay be involved in adhesion to gut cells and colonization
in vivo during infection.
Experimental procedures
Bacterial growth and culture
C. difficile was routinely cultured in TY broth and on BHIS
agar (brain heart infusion agar supplemented with 0.1% L-cys-
teine and 5 mg/ml yeast extract) at 37 °C without shaking,
under anaerobic conditions (80%N2, 10%CO2, 10%H2.)Media
were supplemented where appropriate with thiamphenicol (15
g/ml), cycloserine (250g/ml), cefoxitin (81g/ml), or linco-
mycin (20 g/ml) or erythromycin (5 g/ml). All E. coli strains
were grown using Luria-Bertani broth or agar supplemented,
where necessary, with 12.5 mg/ml chloramphenicol (Sigma) at
37 °C. Strains and plasmids used in this study are shown in
Table S2.
Genetic techniques
C. difficile genomic DNA was isolated as described previ-
ously (54) and plasmids were transferred from E. coli CA434 to
C. difficile strains by conjugation as described previously (30).
PCRs were performed with KOD Hot Start polymerase (Nova-
9 A. Shaw and B. Wren, manuscript in preparation.
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gen) using primers as detailed in Table S2. For construction of
insertional mutants in C. difficile, the ClosTron method was
used (30) with modifications. Retargeted plasmids and the rel-
evant oligonucleotides were designed using the algorithm at
ClosTron, and the plasmidswere synthesized byDNA2.0. Plas-
mids were transformed into E. coli CA4343 and then trans-
ferred by conjugation to C. difficile Ox247, where transconju-
gants were selected on BHIS agar containing 15 g/ml
thiamphenicol (Sigma). Insertion of the intron into the chro-
mosome was by selection of erythromycin (5 g/ml), and colo-
nieswere screened by PCRandDNAsequencing.Mutantswere
confirmed to have only one insertion by Southern blot analysis
(Fig. S3). Mutants were complemented by introducing theWT
geneunder the control of the constitutive Pcwp2promoter or the
anhydrotetracycline-inducible promoter Ptet, as described pre-
viously (26).
S-layer protein purification
S-layer proteins and associated cell wall proteins were pre-
pared by growth of C. difficile strains overnight in 50 ml of BHI
broth. Cells were centrifuged, washed in 0.1 volume of PBS, and
resuspended in 0.01 volume of 0.2 M glycine, pH 2.2. Cells were
mixed by rotation for 30min and centrifuged, and the superna-
tant containing the SLPs was removed and neutralized by the
addition of 2 M Tris base.
Sporulation and cell-length assays
To enumerate spores, overnight cultures ofC. difficile grown
in BHIS medium supplemented with thiamphenicol, where
necessary, were used to inoculate 10 ml of fresh BHIS medium.
At intervals, samples of culture were taken and divided. To
determine the total number of colony-forming units, one sam-
ple was serially diluted and plated on BHIS medium plus 0.1%
taurocholate (Sigma). To determine the number of spores, the
second samplewas heat-killed by incubation for 25min at 65 °C
prior to plating on BHIS medium plus 0.1% taurocholate. The
number of spores was subtracted from the total cell counts to
give the vegetative cell numbers.
To analyze cell length,C. difficile strains were grown in BHIS
broth at 37 °C in an anaerobic chamber for 12 h. 0.5 ml of each
culture was centrifuged at 4000 g for 2 min. Following gentle
resuspension in 150l of 1 PBS, 3l of culture was placed on
top of 1.2% agarose pads and left to dry for 15 min. Slides
were visualized using an Eclipse E600 microscope (Nikon),
using a Plan Fluor 100 objective lens, using oil immersion.
Images were captured using a Retiga 2000R camera, using the
QCapture Pro Software (QImaging), and images were pro-
cessed using the ImageJ software.
Biofilm and adhesion assays
Biofilm formation—Single colonies C. difficile grown on
BHIS agar were used to inoculate pre-reduced BHIS broth.
After overnight incubation, 200 l of each culture at OD600 0.1
was used to inoculate 1.8 ml of pre-reduced BHIS broth on a
24-well plate (Costar).The plates were incubated anaerobically
at 37 °C. After 24 or 72 h, the media were gently removed from
each well, and the wells were gently washed with 1 ml of pre-
reduced PBS. Biofilms were stained with 500 l of 0.1% filter-
sterilized crystal violet for 30min. 500l of 100%methanol was
added to solubilize the crystal violet stain followed by incuba-
tion for 30min at room temperature. TheOD595 of the solution
was then measured using a microplate reader (Bio-Rad). Three
biological replicates were performed for each strain, and the
assay was replicated six times.
Adhesion assay—TC7 cells, a sub-clone of the Caco-2 cell
line, were maintained using Dulbecco’s modified Eagle’s
medium (DMEM), containing 15% fetal bovine saline (Ther-
moFisher Scientific), 1% minimum Eagle’s medium nonessen-
tial amino acids (Life Technologies, Inc.), and 2mMGlutaMAX
(ThermoFisher Scientific). Monolayers were used at 8 days
post-confluency, and cells were given nonsupplemented
DMEM (containing no fetal bovine serum) 24 h prior to infec-
tion. Cells at passage 30–40 were washed with PBS prior to
infection. C. difficile bacteria were prepared at a multiplicity of
infection of 5 in pre-reduced and pre-warmed DMEM. 1 ml of
bacterial cellswas added to eachwell of TC7 cells and incubated
for 2 h. Bacterial suspensionswere then removed, and cellswere
washed three times with pre-reduced BHIS media. Following
vigorous pipetting, TC7 cells with adherent bacteria were
removed from the wells, gently vortexed to remove cell clump-
ing, and enumerated on BHIS agar.
Mass spectrometry
Discovery and glycoproteomic analyses—For discovery and
glycoproteomic experiments, the bands of interest from poly-
acrylamide gels were in-gel digested with trypsin, and the tryp-
tic peptide/glycopeptide digest mixtures, from S-layer C. diffi-
cile Ox247 both WT and mutants, were analyzed directly by
either micro- or nano-LC-ES-MS and MS/MS using Q-TOF
mass spectrometers as described previously (31–38): (a) a
reverse-phase nano-HPLC system ((15 cm  75 mm inner
diameter) PepMap column (LC Packings, Dionex)) connected
to a Q-STAR Pulsar (ABI/MDS SCIEX) and/or (b) a reverse-
phase LC Acquity column (BEH C-18 1  50 mm, Waters)
connected to a Xevo G2 (Waters) instrument. All interpreta-
tions of glycoproteomic data were made manually by visual
inspection (36–38). The site of glycan substitution was deter-
mined using electron capture dissociation on C. difficile WT
samples, and both for this work and studies on the orf3::erm
mutant a Synapt G2-S instrument (Waters) fitted with a nano-
Acquity Ultra Performance LC C18 column (15 cm length, 75
m inner diameter) was used. ETD was achieved using glow
discharge and m-nitrobenzyl alcohol (Sigma) to supercharge
the peptides before mass spectrometric detection (39).
Sugar composition and linkage—GC-MScompositional anal-
ysis of alditol acetates, followingTFAhydrolysis, borodeuteride
reduction, and re-N-acetylation was carried out as described
previously (36). Linkage analysis was achieved by the study of
partially methylated alditol acetate derivatives as described
(40). GC-MS analysis was carried out on a Bruker SCION SQ
456 instrument.
Oligosaccharide and glycopeptide mass and sequence anal-
ysis—The preparation, purification, and permethylation of gly-
cans-eliminated from the protein backbonewas carried out as
described previously (41, 42).MALDI-TOFMSof both free and
derivatized oligosaccharides and of free intact glycopeptides
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was carried out in linear and reflectron modes in both positive
and negative ionization, as appropriate, using a 4800 MALDI
TOF/TOF (ABI SCIEX) mass spectrometer. For MALDI TOF/
TOFMS/MS selected quasi-molecular ions of either permethy-
lated or underivatized species observed in the MS spectra were
subjected to collision-induced dissociation, at a collision energy
of 1 kV with argon as the collision gas (41, 42).
Large-scale glycan purification for NMR analysis
C. difficile Ox247 was grown in BHIS broth (6 1 liter) for
16 h at 37 °C in an anaerobic chamber. Bacterial cells were har-
vested, and the cell pellets were resuspended in 0.2 M glycine
buffer and incubated at room temperature for 20min with gen-
tle mixing. Cells were removed by centrifugation for 15 min in
an Eppendorf microcentrifuge, and glycine supernatants were
neutralized with 1 M Tris. Following dialysis against dH2O for
48 h, the S-layer protein extract was digested with proteinase K
(Sigma) in 10 mM NaPO4, pH 8.0, at 37 °C for 48 h (5:1 ratio
S-layer protein/proteinase K). The digested samples were then
subjected to Amicon filtration (3000-Da cutoff), and the reten-
tate was lyophilized. The lyophilized sample was resuspended
in dH2O and further purified as described below.
Polysaccharides were purified by anion-exchange chroma-
tography onHitrapQ column in a linear gradient fromwater to
1 M NaCl over 1 h with UV detection at 220 nm and a spot test
on TLC plate with development by dipping in 5% H2SO4 in
ethanol and heating with a heat gun until brown spots became
visible, and products were desalted by gel chromatography.
Sampleswere desalted on SephadexG-15 column (1.6 60 cm)
in 1% AcOH with refractive index detector.
NMR spectroscopy
NMRexperimentswere carried out on a BrukerAVANCE III
600 MHz (1H) spectrometer with a 5-mm Z-gradient probe
with acetone internal reference (2.225 ppm for 1H and 31.45
ppm for 13C) using standard pulse sequences cosygpprqf
(gCOSY), mlevphpr (TOCSY, mixing time 120 ms), roesyphpr
(ROESY, mixing time 500 ms), hsqcedetgp (HSQC), hsqcetg-
pml (HSQC-TOCSY, 80ms TOCSY delay), and hmbcgplpndqf
(HMBC, 100-ms long-range transfer delay). Resolution was
kept	3 Hz/point in F2 in proton–proton correlations and	5
Hz/pt in F2 of H–C correlations. The spectra were processed
and analyzed using the Bruker Topspin 2.1 program.
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